GL1X · GenesisL1 explorer

Research workbench

Lack of synergy for inhibitors targeting a multi-drug resistant HIV-1 protease

Analyse Lack of synergy for inhibitors targeting a multi-drug resistant HIV-1 protease in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1K6P
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Pol polyprotein
EC
3.4.23.16
UniProt
P35963
Ligands
XN3
Pockets
1 · best druggability 0.73

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 57% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BPol polyprotein (EC 3.4.23.16)protein994% helix, 57% strandP35963

Ligands and binding sites

  • XN3 · N-[2(R)-hydroxy-1(S)-indanyl]-5-[(2(S)-tertiary butylaminocarbonyl)-4(benzo[1,3]dioxol-5-ylmethyl)-piperazino]-4(S)-hydroxy-2(R)-phenylmethylpentanamide · ligand · chains A, B
  • ACT · Acetate ion · additive · 9 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13690.730.8437XN3

Interfaces

1 interface between chains.

  • A–B · 1822 Ų buried · 41 hydrogen bonds · protein-protein

Compared structures

  • 1K6P · Lack of synergy for inhibitors targeting a multi-drug resistant HIV-1 protease · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.